Prevalence and description of disorders of gut-brain interaction in Spain according to the results of the Rome Foundation Global Epidemiology Study.

Szczegóły
Abstrakt

Tytuł:: Prevalence and description of disorders of gut-brain interaction in Spain according to the results of the Rome Foundation Global Epidemiology Study.
Autorzy:: Flores-Arriaga J; Department of Gastroenterology Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Aso MC; Department of Gastroenterology, Lozano Blesa University Clinical Hospital, Zaragoza, Spain.
Izagirre A; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
Sperber AD; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Palsson OS; Center for Functional GI & Motility Disorders, University of North Carolina-Chapel Hill, North Carolina, Chapel Hill, USA.
Bangdiwala SI; Population Health Research Institute, McMaster University, Ontario, Hamilton, Canada.; Department of Health Research Methods, Evidence and Impact, McMaster University, Ontario, Hamilton, Canada.
Lanas Á; Department of Gastroenterology, Lozano Blesa University Clinical Hospital, Zaragoza, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERHED), Instituto de Salud Carlos III, Madrid, Spain.
Bujanda L; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERHED), Instituto de Salud Carlos III, Madrid, Spain.; Department of Gastroenterology, University of the Basque Country UPV/EHU, San Sebastian, Spain.
Lobo B; Department of Gastroenterology Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Laboratory of Neuro-Immuno-Gastroenterology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
Alonso-Cotoner C; Department of Gastroenterology Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERHED), Instituto de Salud Carlos III, Madrid, Spain.; Laboratory of Neuro-Immuno-Gastroenterology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Facultad de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
Sánchez-Pla Á; Department of genetics, microbiology and statistics, University of Barcelona, Barcelona, Spain.; Statistics and Bioinformatics Unit, Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.
Santos J; Department of Gastroenterology Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERHED), Instituto de Salud Carlos III, Madrid, Spain.; Laboratory of Neuro-Immuno-Gastroenterology, Digestive System Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Facultad de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
Źródło:: Neurogastroenterology and motility [Neurogastroenterol Motil] 2023 Jun; Vol. 35 (6), pp. e14582. Date of Electronic Publication: 2023 Apr 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Original Publication: Osney Mead, Oxford, UK : Blackwell Scientific Publications, c1994-
MeSH Terms:: Quality of Life*
Irritable Bowel Syndrome*/diagnosis
Adult ; Humans ; Female ; Middle Aged ; Male ; Prevalence ; Spain/epidemiology ; Rome ; Surveys and Questionnaires ; Brain
References:: Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study. Gastroenterology. 2021;160:99-114.e3.
Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150:1257-1261.
Black CJ, Drossman DA, Talley NJ, Ruddy J, Ford AC. Functional gastrointestinal disorders: advances in understanding and management. Lancet. 2020;396:1664-1674.
Wong RK, Drossman DA. Quality of life measures in irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2010;4:277-284.
Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M. The prevalence and impact of overlapping Rome IV-diagnosed functional gastrointestinal disorders on somatization, quality of life, and healthcare utilization: a cross-sectional general population study in three countries. Am J Gastroenterol. 2018;113:86-96.
Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther. 2014;40:1023-1034.
Tack J, Stanghellini V, Mearin F, et al. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries. BMC Gastroenterol. 2019;19:69.
Shivaji UN, Ford AC. Prevalence of functional gastrointestinal disorders among consecutive new patient referrals to a gastroenterology clinic. Frontline Gastroenterol. 2014;5:266-271.
Badia X, Mearin F, Balboa A, et al. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics. 2002;20:749-758.
Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns, and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther. 2003;17:643-650.
Mearin F, Badía X, Balboa A, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol. 2001;36:1155-1161.
Rey E, Balboa A, Mearin F. Chronic constipation, irritable bowel syndrome with constipation and constipation with pain/discomfort: similarities and differences. Am J Gastroenterol. 2014;109:876-884.
Almansa C, Díaz-Rubio M, Rey E. The burden and management of patients with IBS: results from a survey in spanish gastroenterologists. Rev Esp Enferm Dig. 2011;103:570-575.
Scarpato E, Kolacek S, Jojkic-Pavkov D, et al. Prevalence of functional gastrointestinal disorders in children and adolescents in the Mediterranean region of Europe. Clin Gastroenterol Hepatol. 2018;16:870-876.
Caballero Plasencia AM, Sofos Kontoyannis S, Valenzuela Barranco M, Martín Ruiz JL, Casado Caballero FJ, Guilarte López-Mañas J. Epidemiology of dyspepsia in a random mediterranean population. Prevalence of helicobacter pylori infection. Rev Esp Enferm Dig. 2000;92:781-792.
Alonso-Bermejo C, Barrio J, Fernández B, et al. Functional gastrointestinal disorders frequency by Rome IV criteria. An Pediatr (Engl ed). 2022;96:441-447.
Caballero-Mateos AM, Redondo CE. Dyspepsia, functional dyspepsia and Rome IV criteria. Rev Esp Enferm Dig. 2018;110:530-531.
Palsson OS, Whitehead WE, van Tilburg MA, et al. Rome IV diagnostic questionnaires and tables for investigators and clinicians. Gastroenterology. 2016;13: S0016-5085(16)00180-3. doi:10.1053/j.gastro.2016.02.014.
Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395-402.
Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64:258-266.
PROMIS Global-10. Accessed April 1, 2019. https://www. codetechnology.com/promis-global-10.
Defining Rural at the U.S. Census Bureau: American Community Survey and Geography Brief. 2016. Accessed January 9, 2023. https://www2.census.gov/geo/pdfs/reference/ua/Defining_Rural.pdf.
INE - Instituto Nacional De Estadística. Población Por Comunidades y Ciudades autónomas y Sexo. 2022. Accessed January 9, 2023. 2023. https://www.ine.es/jaxiT3/Datos.htm?t=2853.
Sperber AD, Freud T, Abu-Freha N, et al. Epidemiology of disorders of gut-brain interaction in Israel: results from the Rome foundation global epidemiology study. Neurogastroenterol Motil. 2022;34:e14323.
Dumitrascu DL, Freud T, Ismaiel A, Bangdiwala SI, Palsson OS, Sperber AD. Epidemiology and burden of disorders of gut-brain interaction in Romania: a subgroup analysis of the Rome foundation global epidemiology study. J Gastrointestin Liver Dis. 2022;31:273-282.
Palsson OS, Whitehead W, Törnblom H, Sperber AD, Simren M. Prevalence of Rome IV functional bowel disorders among adults in the United States, Canada, and the United Kingdom. Gastroenterology. 2020;158:1262-1273.e3.
Aziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simren M. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018;3:252-262.
Azpiroz F et al. In: Drossman DA, ed. Guest Ed, editorMulti-Dimensional Clinical Profile (MDCP) for the Functional Gastrointestinal Disorders. 1st ed. The Rome Foundation; 2015.
Ministerio de agricultura, pesca y alimentación. Demografía de la población rural en 2020 Gobierno de España. 2021. Accessed January 9, 2023. https://www.mapa.gob.es/es/ministerio/servicios/analisis-y-prospectiva/ayp_demografiaenlapoblacionrural2020_tcm30-583987.pdf.
INE - Instituto Nacional De Estadística. Población. Población Residente Por Fecha, Sexo, Grupo de Edad y Lugar de Nacimiento 8agrupación de países. 2023. Accessed January 9, 2023. https://www.ine.es/jaxi/Datos.htm?path=/t20/e245/p08/l0/&file=02005.px.
Contributed Indexing:: Keywords: Rome IV diagnostic criteria; Spain; disorders of gut-brain interaction; epidemiology; functional dyspepsia; irritable bowel syndrome
Entry Date(s):: Date Created: 20230403 Date Completed: 20230504 Latest Revision: 20230504
Update Code:: 20240104
DOI:: 10.1111/nmo.14582
PMID:: 37010843
: Czasopismo naukowe

Full Text Finder

Background: Data for Spain from the Rome Foundation Global Epidemiology Study on the disorders of gut-brain interaction (DGBI) were used to assess the national and regional prevalence of all 22 DGBI, the percentage of respondents meeting diagnostic criteria for at least one DGBI, and the impact on burden of disease in our country.
Methods: Data were collected through an anonymous, nationwide, and secure Internet survey with multiple built-in quality-assurance techniques that included the Rome IV diagnostic questionnaire and an in-depth supplemental questionnaire.
Key Results: The survey was completed by 2072 adult Spanish participants (50.2% female) with a mean age of 45.67 ± 15.44 years with a good representative national distribution. 43.6% (41.5%-45.8%) met diagnostic criteria for at least one DGBI, with 8.2% for any esophageal disorder, 12.1% for any gastroduodenal disorder, 30.1% for any bowel disorder, and 11.5% for any anorectal disorder. Functional constipation was the most prevalent DGBI in Spain (12.8%). We found that proctalgia fugax (9.3%), unspecified bowel disorders (10.8%), and functional dysphagia (5.6%) showed unexplained high rates in our country. DGBI rates were higher for women. Having any DGBI was negatively associated with psychosocial variables (including quality of life, somatization, and concern about digestive problems), and associated with increased healthcare utilization.
Conclusions & Inferences: We provide the first comprehensive data on the prevalence and burden of all DGBI in Spain using the Rome IV criteria. The enormous burden of DGBI in Spain highlights the need for specialized training and future research.
(© 2023 John Wiley & Sons Ltd.)

Informacja